Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort descending Journal
Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. PLOS ONE
Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab Cancer Immunology, Immunotherapy
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel European Urology
Can synthetic data be a proxy for real clinical trial data? A validation study BMJ Open
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications
Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment Journal of Theoretical Biology
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis BMC Cancer
Characteristics of available studies and dissemination of research using major clinical data sharing platforms Clinical Trials
Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data Journal of Cancer
Clinical trial data reuse – overcoming complexities in trial design and data sharing Trials
Community mining of open clinical trial data Oncotarget
Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure The Oncologist
Comparison of outcomes of radiotherapy-treated localized prostate cancer patients within a clinical trial setting versus real-life setting Future Oncology
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors Journal for ImmunoTherapy of Cancer

Pages